Biotechnology – Page 12

Moderna Collaborates with OpenAI for Seamless Integration of GenAI in Operations

1 year ago talkbio0Tagged Artificial Intelligence, Biotechnology, DNA Integration, GenAI, Moderna, OpenAI, Partnership, Seamless, Surgical aspects

Moderna, OpenAI, GenAI, seamless integration, operations, biotechnology, artificial intelligence, partnership

Xaira: The Billion-Dollar AI-Powered Drug Discovery Startup Revolutionizing Healthcare

1 year ago talkbio0Tagged AI, Artificial Intelligence, Biotechnology, Drug Discovery, Health care facility, startup, Xaira

Xaira, AI, drug discovery, healthcare, startup, funding, billion-dollar, revolutionizing, pharmaceuticals, biotechnology.

Revolutionizing Research and Development: Xaira Unveils AI-Driven Platform with $1B Funding and Former Genentech Leaders

1 year ago talkbio0Tagged AI-Powered Xaira, Artificial Intelligence, Biotechnology, cell transformation, Genentech executives, innovation, R&D, research, Surgical advancement - action

AI-Powered Xaira, $1B funding, Genentech executives, R&D transformation, biotechnology innovation, artificial intelligence in research, life sciences advancement.

BenevolentAI Announces Significant Restructuring with Workforce Reduction and US Office Closure

1 year ago talkbio0Tagged Artificial Intelligence, BenevolentAI, Biotechnology, Drug Discovery, Office Closure, reSET (device), restructuring

BenevolentAI, restructuring, workforce reduction, US office closure, reset, artificial intelligence, biotechnology, drug discovery

Incyte Expands Portfolio with $750 Million Acquisition of Escient, a Pioneer in Immune and Neuro Biotechnology

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, Drug Development, Escient, expansion, G-Protein-Coupled Receptors, Immune system, Incyte, Neuroscience discipline, portfolio, targets

Incyte, Escient, biotechnology, immune system, neuroscience, acquisition, deal, $750 million, portfolio expansion, drug development, therapeutics, GPCR targets.

Sanofi’s Strategic Acquisition of Principia Bears Fruit with Rilzabrutinib’s Phase III Success

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, Clinical Trials, Drug Development, Drug Industry, Investments, Phase III, Principia, Rilzabrutinib, sanofi, strategic, Success

Sanofi, Principia, acquisition, Rilzabrutinib, Phase III, clinical trial, success, strategic investment, pharmaceutical industry, biotechnology, drug development.

BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares

1 year ago talkbio0Tagged Automation, Biotechnology, Burning Mouth Syndrome, Cancer Therapeutic Procedure, Capacity, CAR-T, Cell Therapy, Cellares, expansion, Investments, Manufacture, squibb

BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.